Theraclion SA (EPA:ALTHE)

Market Cap	23.49M +165.1%
Revenue (ttm)	1.87M +210.9%
Net Income	-5.25M
EPS	n/a
Shares Out	46.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,001
Average Volume	31,939
Open	0.5100
Previous Close	0.5100
Day's Range	0.4940 - 0.5100
52-Week Range	0.1416 - 1.2500
Beta	-0.13
RSI	36.43
Earnings Date	Apr 16, 2026

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 31
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTHE

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.